annual SGA:
$38.55M+$7.63M(+24.69%)Summary
- As of today (July 4, 2025), CLDX annual SGA is $38.55 million, with the most recent change of +$7.63 million (+24.69%) on December 31, 2024.
- During the last 3 years, CLDX annual SGA has risen by +$18.06 million (+88.15%).
- CLDX annual SGA is now at all-time high.
Performance
CLDX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$10.82M+$557.00K(+5.43%)Summary
- As of today (July 4, 2025), CLDX quarterly SGA is $10.82 million, with the most recent change of +$557.00 thousand (+5.43%) on March 31, 2025.
- Over the past year, CLDX quarterly SGA has increased by +$1.72 million (+18.86%).
- CLDX quarterly SGA is now -9.30% below its all-time high of $11.93 million, reached on December 31, 2016.
Performance
CLDX quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
-$6.14B-$178.85M(-3.00%)Summary
- As of today (July 4, 2025), CLDX TTM SGA is -$6.14 billion, with the most recent change of -$178.85 million (-3.00%) on March 31, 2025.
- Over the past year, CLDX TTM SGA has dropped by -$6.17 billion (-18491.07%).
- CLDX TTM SGA is now -211568.52% below its all-time high of -$2.90 million.
Performance
CLDX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
CLDX Selling, general & administrative expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +24.7% | +18.9% | -10000.0% |
3 y3 years | +88.2% | +56.6% | -10000.0% |
5 y5 years | +149.9% | +195.1% | -10000.0% |
CLDX Selling, general & administrative expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +88.2% | at high | +65.7% | -32.4% | at low |
5 y | 5-year | at high | +166.7% | at high | +206.7% | -50.5% | at low |
alltime | all time | at high | +1928.8% | -9.3% | +345.0% | <-9999.0% | at low |
CLDX Selling, general & administrative expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $10.82M(+5.4%) | $40.27M(+4.5%) |
Dec 2024 | $38.55M(+24.7%) | $10.26M(+2.1%) | $38.55M(+3.9%) |
Sep 2024 | - | $10.05M(+10.1%) | $37.12M(+5.2%) |
Jun 2024 | - | $9.13M(+0.3%) | $35.28M(+5.7%) |
Mar 2024 | - | $9.10M(+3.1%) | $33.38M(+8.0%) |
Dec 2023 | $30.91M(+13.7%) | $8.83M(+7.4%) | $30.91M(+7.8%) |
Sep 2023 | - | $8.22M(+13.8%) | $28.68M(+6.3%) |
Jun 2023 | - | $7.22M(+8.8%) | $26.99M(+0.2%) |
Mar 2023 | - | $6.64M(+0.6%) | $26.92M(-1.0%) |
Dec 2022 | $27.20M(+32.7%) | $6.60M(+1.0%) | $27.20M(+1.3%) |
Sep 2022 | - | $6.53M(-8.7%) | $26.84M(+2.7%) |
Jun 2022 | - | $7.15M(+3.5%) | $26.13M(+12.2%) |
Mar 2022 | - | $6.91M(+10.7%) | $23.28M(+13.6%) |
Dec 2021 | $20.49M(+41.7%) | $6.24M(+7.2%) | $20.49M(+14.6%) |
Sep 2021 | - | $5.82M(+35.2%) | $17.87M(+13.9%) |
Jun 2021 | - | $4.31M(+4.5%) | $15.69M(+5.2%) |
Mar 2021 | - | $4.12M(+13.7%) | $14.91M(+3.1%) |
Dec 2020 | $14.46M(-6.3%) | $3.62M(-0.5%) | $14.46M(+2.9%) |
Sep 2020 | - | $3.64M(+3.2%) | $14.05M(+1.7%) |
Jun 2020 | - | $3.53M(-3.8%) | $13.82M(-2.7%) |
Mar 2020 | - | $3.67M(+13.9%) | $14.20M(-8.0%) |
Dec 2019 | $15.43M(-19.9%) | $3.22M(-5.4%) | $15.43M(-6.7%) |
Sep 2019 | - | $3.40M(-12.9%) | $16.54M(-1.9%) |
Jun 2019 | - | $3.91M(-20.2%) | $16.86M(-9.2%) |
Mar 2019 | - | $4.90M(+13.0%) | $18.57M(-3.6%) |
Dec 2018 | $19.27M(-22.9%) | $4.33M(+16.4%) | $19.27M(-7.5%) |
Sep 2018 | - | $3.72M(-33.8%) | $20.83M(-7.2%) |
Jun 2018 | - | $5.62M(+0.5%) | $22.45M(-3.9%) |
Mar 2018 | - | $5.59M(-5.1%) | $23.37M(-6.5%) |
Dec 2017 | $25.00M(-30.5%) | $5.89M(+10.3%) | $25.00M(-19.4%) |
Sep 2017 | - | $5.35M(-18.2%) | $31.04M(-4.9%) |
Jun 2017 | - | $6.53M(-9.6%) | $32.64M(-3.7%) |
Mar 2017 | - | $7.23M(-39.4%) | $33.90M(-5.8%) |
Dec 2016 | $35.98M(+6.3%) | $11.93M(+71.7%) | $35.98M(+2.4%) |
Sep 2016 | - | $6.95M(-10.8%) | $35.12M(-4.2%) |
Jun 2016 | - | $7.79M(-16.3%) | $36.66M(-1.1%) |
Mar 2016 | - | $9.31M(-16.0%) | $37.05M(+9.5%) |
Dec 2015 | $33.84M(+64.1%) | $11.08M(+30.5%) | $33.84M(+16.6%) |
Sep 2015 | - | $8.49M(+3.7%) | $29.01M(+13.6%) |
Jun 2015 | - | $8.18M(+34.4%) | $25.53M(+15.4%) |
Mar 2015 | - | $6.09M(-2.6%) | $22.13M(+7.3%) |
Dec 2014 | $20.62M(+39.3%) | $6.25M(+24.9%) | $20.62M(+8.3%) |
Sep 2014 | - | $5.00M(+4.5%) | $19.05M(+8.1%) |
Jun 2014 | - | $4.79M(+4.5%) | $17.62M(+8.5%) |
Mar 2014 | - | $4.58M(-2.0%) | $16.25M(+9.8%) |
Dec 2013 | $14.80M(+47.8%) | $4.68M(+30.7%) | $14.80M(+15.9%) |
Sep 2013 | - | $3.58M(+4.9%) | $12.77M(+6.2%) |
Jun 2013 | - | $3.41M(+8.7%) | $12.03M(+11.0%) |
Mar 2013 | - | $3.14M(+18.7%) | $10.84M(+8.2%) |
Dec 2012 | $10.02M(+9.0%) | $2.64M(-6.7%) | $10.02M(+239.0%) |
Sep 2012 | - | $2.83M(+27.8%) | $2.95M(-37.3%) |
Jun 2012 | - | $2.22M(-4.2%) | $4.71M(-0.4%) |
Mar 2012 | - | $2.32M(-152.5%) | $4.73M(-0.4%) |
Dec 2011 | $9.19M(-11.4%) | -$4.42M(-196.2%) | $4.75M(-59.4%) |
Sep 2011 | - | $4.59M(+105.0%) | $11.70M(+22.8%) |
Jun 2011 | - | $2.24M(-4.1%) | $9.53M(-3.6%) |
Mar 2011 | - | $2.34M(-7.7%) | $9.88M(-4.8%) |
Dec 2010 | $10.38M(-39.4%) | $2.53M(+4.5%) | $10.38M(-27.3%) |
Sep 2010 | - | $2.42M(-6.6%) | $14.27M(-9.1%) |
Jun 2010 | - | $2.59M(-8.6%) | $15.69M(-5.5%) |
Mar 2010 | - | $2.83M(-55.8%) | $16.61M(-3.0%) |
Dec 2009 | $17.12M(+16.1%) | $6.42M(+66.7%) | $17.12M(+25.7%) |
Sep 2009 | - | $3.85M(+9.7%) | $13.62M(-2.5%) |
Jun 2009 | - | $3.51M(+5.1%) | $13.98M(-7.3%) |
Mar 2009 | - | $3.34M(+14.3%) | $15.08M(+2.1%) |
Dec 2008 | $14.75M(+113.6%) | $2.92M(-30.5%) | $14.77M(-0.7%) |
Sep 2008 | - | $4.21M(-8.7%) | $14.87M(+24.2%) |
Jun 2008 | - | $4.61M(+51.9%) | $11.97M(+42.3%) |
Mar 2008 | - | $3.03M(+0.4%) | $8.41M(+21.8%) |
Dec 2007 | $6.91M(-27.8%) | $3.02M(+131.4%) | $6.91M(-8.2%) |
Sep 2007 | - | $1.31M(+24.5%) | $7.52M(-6.4%) |
Jun 2007 | - | $1.05M(-31.3%) | $8.04M(-11.7%) |
Mar 2007 | - | $1.53M(-58.0%) | $9.10M(-4.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2006 | $9.56M(+38.7%) | $3.64M(+100.1%) | $9.56M(+26.2%) |
Sep 2006 | - | $1.82M(-14.1%) | $7.58M(+2.0%) |
Jun 2006 | - | $2.12M(+6.5%) | $7.43M(+3.6%) |
Mar 2006 | - | $1.99M(+20.3%) | $7.17M(+4.0%) |
Dec 2005 | $6.89M(+23.7%) | $1.65M(-1.0%) | $6.89M(-1.0%) |
Sep 2005 | - | $1.67M(-10.3%) | $6.96M(+5.8%) |
Jun 2005 | - | $1.86M(+8.8%) | $6.58M(+9.9%) |
Mar 2005 | - | $1.71M(-0.5%) | $5.99M(+7.5%) |
Dec 2004 | $5.57M(+4.1%) | $1.72M(+33.2%) | $5.57M(+7.1%) |
Sep 2004 | - | $1.29M(+1.6%) | $5.20M(-2.5%) |
Jun 2004 | - | $1.27M(-1.7%) | $5.34M(-1.5%) |
Mar 2004 | - | $1.29M(-4.3%) | $5.42M(+1.3%) |
Dec 2003 | $5.35M(-4.3%) | $1.35M(-5.1%) | $5.35M(-0.8%) |
Sep 2003 | - | $1.42M(+5.3%) | $5.39M(+1.9%) |
Jun 2003 | - | $1.35M(+10.4%) | $5.30M(-6.0%) |
Mar 2003 | - | $1.22M(-12.1%) | $5.63M(+0.7%) |
Dec 2002 | $5.59M(+13.8%) | $1.39M(+5.1%) | $5.59M(+2.3%) |
Sep 2002 | - | $1.33M(-21.4%) | $5.46M(+0.1%) |
Jun 2002 | - | $1.69M(+42.3%) | $5.46M(+10.1%) |
Mar 2002 | - | $1.19M(-6.3%) | $4.96M(-0.6%) |
Dec 2001 | $4.91M(+2.2%) | $1.27M(-4.3%) | $4.99M(-6.5%) |
Sep 2001 | - | $1.32M(+11.2%) | $5.34M(+5.4%) |
Jun 2001 | - | $1.19M(-2.1%) | $5.07M(+3.0%) |
Mar 2001 | - | $1.21M(-24.7%) | $4.92M(+2.3%) |
Dec 2000 | $4.81M(+12.3%) | $1.61M(+53.6%) | $4.81M(+0.7%) |
Sep 2000 | - | $1.05M(+0.8%) | $4.78M(+5.5%) |
Jun 2000 | - | $1.04M(-5.5%) | $4.52M(+0.9%) |
Mar 2000 | - | $1.10M(-30.2%) | $4.48M(+2.3%) |
Dec 1999 | $4.28M(+12.6%) | $1.58M(+97.5%) | $4.38M(+4.3%) |
Sep 1999 | - | $800.00K(-20.0%) | $4.20M(-2.3%) |
Jun 1999 | - | $1.00M(0.0%) | $4.30M(+7.5%) |
Mar 1999 | - | $1.00M(-28.6%) | $4.00M(+8.1%) |
Dec 1998 | $3.80M(+8.6%) | $1.40M(+55.6%) | $3.70M(+19.4%) |
Sep 1998 | - | $900.00K(+28.6%) | $3.10M(0.0%) |
Jun 1998 | - | $700.00K(0.0%) | $3.10M(-11.4%) |
Mar 1998 | - | $700.00K(-12.5%) | $3.50M(-2.8%) |
Dec 1997 | $3.50M(-46.2%) | $800.00K(-11.1%) | $3.60M(-14.3%) |
Sep 1997 | - | $900.00K(-18.2%) | $4.20M(0.0%) |
Jun 1997 | - | $1.10M(+37.5%) | $4.20M(-33.3%) |
Mar 1997 | - | $800.00K(-42.9%) | $6.30M(-3.1%) |
Dec 1996 | $6.50M(+10.2%) | $1.40M(+55.6%) | $6.50M(-3.0%) |
Sep 1996 | - | $900.00K(-71.9%) | $6.70M(-9.5%) |
Jun 1996 | - | $3.20M(+220.0%) | $7.40M(+34.5%) |
Mar 1996 | - | $1.00M(-37.5%) | $5.50M(-6.8%) |
Dec 1995 | $5.90M(+1.7%) | $1.60M(0.0%) | $5.90M(+5.4%) |
Sep 1995 | - | $1.60M(+23.1%) | $5.60M(+5.7%) |
Jun 1995 | - | $1.30M(-7.1%) | $5.30M(-7.0%) |
Mar 1995 | - | $1.40M(+7.7%) | $5.70M(-1.7%) |
Dec 1994 | $5.80M(-63.7%) | $1.30M(0.0%) | $5.80M(-30.1%) |
Sep 1994 | - | $1.30M(-23.5%) | $8.30M(-25.9%) |
Jun 1994 | - | $1.70M(+13.3%) | $11.20M(-17.6%) |
Mar 1994 | - | $1.50M(-60.5%) | $13.60M(-15.0%) |
Dec 1993 | $16.00M(+58.4%) | $3.80M(-9.5%) | $16.00M(+31.1%) |
Sep 1993 | - | $4.20M(+2.4%) | $12.20M(+2.5%) |
Jun 1993 | - | $4.10M(+5.1%) | $11.90M(+6.3%) |
Mar 1993 | - | $3.90M(0.0%) | $11.20M(-23.8%) |
Dec 1992 | $10.10M(-26.3%) | - | - |
Oct 1992 | - | $3.90M(+14.7%) | $14.70M(+4.3%) |
Jul 1992 | - | $3.40M(-12.8%) | $14.10M(+2.9%) |
Apr 1992 | - | $3.90M(+11.4%) | $13.70M(+5.4%) |
Apr 1992 | $13.70M(+6.2%) | - | - |
Jan 1992 | - | $3.50M(+6.1%) | $13.00M(+2.4%) |
Oct 1991 | - | $3.30M(+10.0%) | $12.70M(+0.8%) |
Jul 1991 | - | $3.00M(-6.3%) | $12.60M(-2.3%) |
Apr 1991 | $12.90M(+12.2%) | $3.20M(0.0%) | $12.90M(+1.6%) |
Jan 1991 | - | $3.20M(0.0%) | $12.70M(-0.8%) |
Oct 1990 | - | $3.20M(-3.0%) | $12.80M(+33.3%) |
Jul 1990 | - | $3.30M(+10.0%) | $9.60M(+52.4%) |
Apr 1990 | $11.50M(+38.6%) | $3.00M(-9.1%) | $6.30M(+90.9%) |
Jan 1990 | - | $3.30M | $3.30M |
Apr 1989 | $8.30M(+36.1%) | - | - |
Apr 1988 | $6.10M(+64.9%) | - | - |
Apr 1987 | $3.70M(+94.7%) | - | - |
Apr 1986 | $1.90M | - | - |
FAQ
- What is Celldex Therapeutics annual SGA?
- What is the all time high annual SGA for Celldex Therapeutics?
- What is Celldex Therapeutics annual SGA year-on-year change?
- What is Celldex Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Celldex Therapeutics?
- What is Celldex Therapeutics quarterly SGA year-on-year change?
- What is Celldex Therapeutics TTM SGA?
- What is the all time high TTM SGA for Celldex Therapeutics?
- What is Celldex Therapeutics TTM SGA year-on-year change?
What is Celldex Therapeutics annual SGA?
The current annual SGA of CLDX is $38.55M
What is the all time high annual SGA for Celldex Therapeutics?
Celldex Therapeutics all-time high annual SGA is $38.55M
What is Celldex Therapeutics annual SGA year-on-year change?
Over the past year, CLDX annual SGA has changed by +$7.63M (+24.69%)
What is Celldex Therapeutics quarterly SGA?
The current quarterly SGA of CLDX is $10.82M
What is the all time high quarterly SGA for Celldex Therapeutics?
Celldex Therapeutics all-time high quarterly SGA is $11.93M
What is Celldex Therapeutics quarterly SGA year-on-year change?
Over the past year, CLDX quarterly SGA has changed by +$1.72M (+18.86%)
What is Celldex Therapeutics TTM SGA?
The current TTM SGA of CLDX is -$6.14B
What is the all time high TTM SGA for Celldex Therapeutics?
Celldex Therapeutics all-time high TTM SGA is -$2.90M
What is Celldex Therapeutics TTM SGA year-on-year change?
Over the past year, CLDX TTM SGA has changed by -$6.17B (-18491.07%)